CVKD Chart
See on advanced chart >
About
Cadrenal Therapeutics, Inc. was incorporated as a Delaware corporation on January 25, 2022. They are focused on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of...
Read More
- HighlightA biopharmaceutical company for the prevention of cardiogenic systemic thromboembolism in patients with end-stage renal disease and atrial fibrillation
- ExchangeNASDAQ
- Listing Date01/20/2023
- Established Date01/25/2022
- Full-time Employees4
- Address822 A1A North Suite 320 Ponte Vedra Florida 32082
- Tel1-904-3000701
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals